4//SEC Filing
Voytas Daniel F 4
Accession 0001127602-18-036959
CIK 0001705843other
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 4:16 PM ET
Size
13.7 KB
Accession
0001127602-18-036959
Insider Transaction Report
Form 4
Calyxt, Inc.CLXT
Voytas Daniel F
Chief Science Officer
Transactions
- Sale
Common Stock
2018-12-18$13.00/sh−4,083$53,079→ 92,982 total - Exercise/Conversion
Common Stock
2018-12-18$3.71/sh+4,083$15,165→ 97,065 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-12-18−4,083→ 12,253 totalExercise: $3.71Exp: 2024-12-03→ Common Stock (4,083 underlying)
Footnotes (3)
- [F1]Includes 85,443 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 15,078 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.
- [F3]The stock option to purchase shares of Calyxt, Inc. common stock ("Stock Option") was granted on December 3, 2014, and vests 20% on January 3, 2015 and 20% on April 10, 2015, with the remainder vesting quarterly in equal installments over the following three years (or with an additional 25% vesting immediately if Calyxt, Inc. undergoes a change in control, liquidation, dissolution or initial public offering and the remainder vesting quarterly thereafter).
Documents
Issuer
Calyxt, Inc.
CIK 0001705843
Entity typeother
Related Parties
1- filerCIK 0001712191
Filing Metadata
- Form type
- 4
- Filed
- Dec 19, 7:00 PM ET
- Accepted
- Dec 20, 4:16 PM ET
- Size
- 13.7 KB